Economic considerations for pertussis booster vaccination in adolescents.
about
Infectious diseases and vaccination strategies: how to protect the "unprotectable"?Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data.Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.A critical literature review of health economic evaluations in pertussis booster vaccination.
P2860
Economic considerations for pertussis booster vaccination in adolescents.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Economic considerations for pertussis booster vaccination in adolescents.
@ast
Economic considerations for pertussis booster vaccination in adolescents.
@en
type
label
Economic considerations for pertussis booster vaccination in adolescents.
@ast
Economic considerations for pertussis booster vaccination in adolescents.
@en
prefLabel
Economic considerations for pertussis booster vaccination in adolescents.
@ast
Economic considerations for pertussis booster vaccination in adolescents.
@en
P1476
Economic considerations for pertussis booster vaccination in adolescents.
@en
P2093
Joel I Ward
Joel W Hay
P304
P356
10.1097/01.INF.0000166160.23976.35
P433
P577
2005-06-01T00:00:00Z